Could cause temporary or reversible harm; serious harm is unlikely.
Failed Dissolution Specifications; product failed to meet 18-month stability testing acceptance criteria
| Brand name | PRASUGREL |
| Generic name | PRASUGREL |
| Active ingredient(s) | PRASUGREL HYDROCHLORIDE |
| Distributed by / for | Mylan Pharmaceuticals Inc., Morgantown, WV 26505, Made in India |
| NDC | 0378-5186-93 |
| Full product label | Prasugrel Tablets, USP, 10mg, Rx only, 30 Tablets in each bottle, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505, Made in India, NDC 0378-5186-93. |
| Recalling firm | Mylan Pharmaceuticals Inc |
| Distribution | Nationwide within the U.S |
| Quantity | 47,662 bottles |
| Recall initiated | 2026-08-17 |
| Report date | 2026-09-09 |
| Recall completed | — |
| Recall number | D-0839-2026 |
| Classification | Class II |
| FDA status | Ongoing |
| Origin on file | Morgantown WV United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗